Cargando…
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
The survival of most patients with advanced stage non-small cell lung cancer is prolonged by several months when they are treated with first- and next-generation inhibitors targeting ALK rearrangements, but resistance inevitably emerges. Some of the mechanisms of resistance are sensitive to novel AL...
Autor principal: | Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830674/ https://www.ncbi.nlm.nih.gov/pubmed/33467720 http://dx.doi.org/10.3390/cells10010168 |
Ejemplares similares
-
ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
por: Hofman, Paul
Publicado: (2017) -
Sensitive detection of microsatellite instability in tissues and liquid biopsies: Recent developments and updates
por: Yu, Fangyan, et al.
Publicado: (2021) -
Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC
por: Ferreira, Daniela, et al.
Publicado: (2021) -
ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice
por: Hofman, Paul
Publicado: (2017) -
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020)